hydrosalpinx
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged between 23-40 years; 2. Salpingography for diagnosis of Unilateral or bilateral hydrosalpinx 3. The uterine cavity is intact 4. Planned IVF-ET assisted pregnancy or conceived naturally 5. The subject can understand the purpose of the trial, voluntarily participate and sign the informed consent form and express recognition of the risks and benefits described in the informed consent form and accept follow-up visits
Exclusion criteria
Exclusion criteria: 1. Gynecological underlying diseases that affect interventional surgery, such as endometrial lesions, uterine malformations, and uterine fibroids 2. Patients with individuals infected with acute or subacute inflammation of both internal and external genitalia. 3. Patients with severe heart brain and lung disease and severe liver and kidney dysfunction lead to cannot tolerate surgery 4. Patients with unexplained persistent uterine bleeding 5. Individuals with menstrual cycle disorders 6. The patient has a clear history of allergies to platinum-tungsten alloy 7. Patients with unstable hyperthyroidism treatment 8. Asthma patients in the onset period; 9. Patients with a history of repeated failed embolization device implantation; 10. Diagnosed with severe diseases such as advanced cancer patients who life expectancy less than 12 months could not complete the study follow-up 11. Women who are pregnant or breastfeeding 12. Is participating in any other clinical trial 13. Patients with poor compliance and unable to follow up as planned; 14. 14Other conditions deemed unsuitable for participation in this clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete occlusion rate of target fallopian tubes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Implant success rate; | — |
Countries
China
Contacts
Obstertrics&Gynecology Hosptial of Fudan University